What question did this study set out to answer?

The study aims to explore a hypothesis for using allogeneic whole-cell immunotherapy to enhance anti-tumor immune responses.

May 15, 2026Open Access

Allogeneic Whole-Cell Immunotherapy: A Medical Hypothesis for Breaking Tumor Tolerance via Allo-reactivity and Intermolecular Epitope Spreading

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial proposes allogeneic whole-cell immunotherapy could convert cold tumors to hot, suggesting a new cancer treatment method.

The study aims to explore a hypothesis for using allogeneic whole-cell immunotherapy to enhance anti-tumor immune responses.
Proposing subcutaneous injection of irradiated allogeneic cancer cells as a live vaccine.
Evaluating the immune response triggered by foreign Major Histocompatibility Complex molecules.
Investigating the activation of CD8+ T cells through intermolecular epitope spreading.
Proposed approach may serve as a scalable, low-cost therapy for advanced malignancies.
Hypothesized that allo-response enhances cross-presentation of tumor-associated antigens.
Suggested converting cold tumors into hot tumors could improve overall treatment efficacy.

Wai Kwan Tse (2016) studied this question.

View Full Paper

Ask AI

Bookmark